14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling

HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathway

(2016) Jianhua Zhu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis

(2016) Wei Lv et al.   CANCER LETTERS

Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)

(2015) JING HUANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer

(2014) Xiaolong Wei et al.   BMC CANCER

Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance

(2014) Yulong Shang et al.   CURRENT CANCER DRUG TARGETS

An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

(2014) Laetitia Seguin et al.   NATURE CELL BIOLOGY

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway

(2014) TIAN WANG et al.   Oncology Letters

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer

(2011) Dingzhi Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice

(2011) Dipak Panigrahy et al.   JOURNAL OF CLINICAL INVESTIGATION

PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells

(2011) P P Shah et al.   ONCOGENE

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

(2011) L Sun et al.   ONCOGENE

Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists

(2010) Kasem Nithipatikom et al.   CANCER SCIENCE

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

(2010) Zhiwei Wang et al.   DRUG RESISTANCE UPDATES

Focal adhesion kinase mediates TGF-β1-induced renal tubular epithelial-to-mesenchymal transition in vitro

(2010) Bingqing Deng et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression

(2010) M K Wendt et al.   ONCOGENE

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

(2009) T. Arumugam et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

(2009) Jose Miguel López-Novoa et al.   EMBO Molecular Medicine

Epithelial–mesenchymal transition in tumor metastasis: a method to the madness

(2009) Venkateshwar G Keshamouni et al.   Future Oncology

Collective Epithelial Migration and Cell Rearrangements Drive Mammary Branching Morphogenesis

(2008) Andrew J. Ewald et al.   DEVELOPMENTAL CELL

Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology

(2008) Ingrid Fleming   TRENDS IN CARDIOVASCULAR MEDICINE